Condition: Healthy Participants · Sponsor: Teikoku Seiyaku Co., Ltd.
This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.
This description comes directly from the study's public registry record.
Yoshiyuki Taneoka · +813-6264-9123 · y-taneoka@teiyaku.co.jp
Always discuss trial participation with your own doctor first.
| Deutsche Sporthochschule Köln | Am Sportpark Muengersdorf 6, Clogne, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07307794